Skip to main content
Medicine logoLink to Medicine
. 2015 Oct 30;94(43):e9217. doi: 10.1097/01.md.0000473517.85992.17

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database: Erratum

PMCID: PMC5017261

In the article “Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database”,1 which appeared in Volume 94, Issue 39 of Medicine, the term “fluoroquinolones” was originally misspelled in the abstract. The article has since been corrected online.

REFERENCE

  • 1.Lee L-TG, Lee S-H, Chang S-S, et al. Comparative treatment failure rates of respiratory fluoroquinolones or β-lactam + macrolide versus β-lactam alone in the treatment for community-acquired pneumonia in adult outpatients: An analysis of a nationally representative claims database. Medicine. 2015;94:e1662. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES